Related content

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer

By Hatano Koji   Nishimura Kazuo   Nakai Yasutomo   Yoshida Takahiro   Sato Mototaka   Kawashima Atsunari   Mukai Masatoshi   Nagahara Akira   Uemura Motohide   Oka Daizo   Nakayama Masashi   Takayama Hitoshi   Shimizu Kiyonori   Meguro Norio   Tanigawa Tsuyoshi   Yamaguchi Seiji   Tsujimura Akira   Nonomura Norio  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 704-710

Springer Publishing Company

Access to resources Recommend Favorite

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

By Steineck Gunnar   Glimelius Bengt  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1589-1592

Informa Healthcare

Access to resources Recommend Favorite

Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 303-307

Science Publishers

Access to resources Recommend Favorite

Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment

By Nakai Yasutomo   Nishimura Kazuo   Nakayama Masashi   Uemura Motohide   Takayama Hitoshi   Nonomura Norio   Tsujimura Akira  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan

By Nishimura Kazuo  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 306-313

Springer Publishing Company

Access to resources Recommend Favorite